OMedLive

CME Presentations

Lung Immunotherapy


Presentations


Speakers


CME Information

Recent Advances in Non-Small Cell Lung Cancer (NSCLC) with Immunotherapy: Optimizing Treatment Sequencing and Managing Toxicity


LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Determine if checkpoint inhibitors are appropriate in the first-line setting for patients with advanced/metastatic NSCLC
  • Address immunotherapy-associated adverse events in treated patients with NSCLC in accordance with current recommendations
  • Sequence immunotherapies based on disease- and patient-specific characteristics in the second-line setting for NSCLC
  • Review the use of PD-L1 and other potential biomarker testing for the treatment selection process for patients with NSCLC

Acknowledgement

This activity is supported by educational grants from Bristol-Myers Squibb, Lilly, and Merck Sharp & Dohme Corp. For more information concerning Lilly grant funding visit www.lillygrantoffice.com.

Tuition

Complimentary

Accreditation Statement

The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements

Live Internet Activity

Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

The American Academy of Nurse Practitioners (AANP) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Date of Release/Expiration

Live Internet Activity
Monday, January 14, 2019 from 10:00am – 11:00am EDT.

Enduring Material
The enduring material will be available from January 14, 2019 to July 14, 2019.

Target Audience

This activity is intended for oncologists, oncology nurses, nurse practitioners, physician assistants, hospital pharmacists, internists, primary care physicians, pulmonologists and other specialists who treat patients with lung cancer.

Estimated Time to Complete

This activity consists of one session, which should take approximately 1 hour to complete.

Method of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Faculty Disclosure

The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

Presenter

Lecia V. Sequist, MD
Consulting Fees: AstraZeneca, Blueprint, Genentech, Merrimack

Contracted Research: AstraZeneca, Blueprint, Boehringer Ingelheim, Loxo, Merrimack, Novartis

Peer Reviewer

Rasim A. Gucalp, MD
Has nothing to disclose relevant to this activity

Providers

Einstein-Montefiore Center for Continuing Medical Education
The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Agnes Lee, PhD
Medical Director
PlatformQ Health Education, LLC

None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Discalimers (if applicable)

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, OMedLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Contact Information

Accreditation Support:
Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact OMedLive at (877) 394-1306 or at Support@OMedLive.com